These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. Fleischmann A; Schobinger S; Schumacher M; Thalmann GN; Studer UE Prostate; 2009 Mar; 69(4):352-62. PubMed ID: 19016478 [TBL] [Abstract][Full Text] [Related]
7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
8. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer. Sung MT; Lin H; Koch MO; Davidson DD; Cheng L Am J Surg Pathol; 2007 Feb; 31(2):311-8. PubMed ID: 17255778 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Nakamura K; Ozaki N; Yamada T; Hata T; Sugimoto S; Hikino H; Kanazawa A; Tokuka A; Nagaoka S Surgery; 2005 May; 137(5):511-7. PubMed ID: 15855922 [TBL] [Abstract][Full Text] [Related]
12. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451 [TBL] [Abstract][Full Text] [Related]
13. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940 [TBL] [Abstract][Full Text] [Related]
14. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
15. Study of prostate cancer pathologic features in Chinese populations. Chuang AY; Chang SJ; Horng CF; Tsou MH Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Oosterkamp S; de Jong JM; Van den Ende PL; Manni JJ; Dehing-Oberije C; Kremer B Laryngoscope; 2006 Nov; 116(11):2067-70. PubMed ID: 17075409 [TBL] [Abstract][Full Text] [Related]
18. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346 [TBL] [Abstract][Full Text] [Related]